A Population of Heterogeneous Breast Cancer Patient-Derived Xenografts Demonstrate Broad Activity of PARP Inhibitor in BRCA1/2 Wild-Type Tumors

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Kurt W EvansFunda Meric-Bernstam

Abstract

Background: Breast cancer patients who do not respond to neoadjuvant therapy have a poor prognosis. There is a pressing need for novel targets and models for preclinical testing. Here we report characterization of breast cancer patient-derived xenografts (PDX) largely generated from residual tumors following neoadjuvant chemotherapy.Experimental Design: PDXs were derived from surgical samples of primary or locally recurrent tumors. Normal and tumor DNA sequencing, RNASeq, and reverse phase protein arrays (RPPA) were performed. Phenotypic profiling was performed by determining efficacy of a panel of standard and investigational agents.Results: Twenty-six PDXs were developed from 25 patients. Twenty-two were generated from residual disease following neoadjuvant chemotherapy, and 24 were from triple-negative breast cancer (TNBC). These PDXs harbored a heterogeneous set of genomic alterations and represented all TNBC molecular subtypes. On RPPA, PDXs varied in extent of PI3K and MAPK activation. PDXs also varied in their sensitivity to chemotherapeutic agents. PI3K, mTOR, and MEK inhibitors repressed growth but did not cause tumor regression. The PARP inhibitor talazoparib caused dramatic regression in five of 12 PDXs. Notably, fou...Continue Reading

References

Jul 4, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Elisabetta MarangoniMarie-France Poupon
Jul 15, 2009·Clinical Breast Cancer·Carey K Anders, Lisa A Carey
Jul 8, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bryan T J HennessyGordon B Mills
Jun 3, 2011·The Journal of Clinical Investigation·Brian D LehmannJennifer A Pietenpol
Aug 9, 2012·Cancer Informatics·Xi ChenJennifer A Pietenpol
Sep 25, 2012·Nature·UNKNOWN Cancer Genome Atlas Network
Jul 25, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yuqiao ShenAlan Ashworth
Aug 21, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hiroko MasudaNaoto T Ueno
Oct 9, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antonio C WolffUNKNOWN College of American Pathologists
Nov 21, 2013·Journal of Experimental & Clinical Cancer Research : CR·Maria Saveria Gilardini MontaniSilvia Soddu
Feb 19, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ingrid A MayerJennifer A Pietenpol
May 7, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alba Matas-CéspedesPatricia Pérez-Galán
Jun 5, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Funda Meric-BernstamGordon B Mills
Dec 21, 2014·Journal of Medical Genetics·Laura SpinelliNicholas R Leslie
Jan 30, 2015·Clinical Chemistry·Ken ChenAgda Karina Eterovic
Apr 8, 2015·Breast Cancer Research : BCR·James R WhittleJane E Visvader
Apr 17, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S MoulderR Kurzrock
May 7, 2015·Oncotarget·Ashley M HolderFunda Meric-Bernstam
Aug 21, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Magdalena BieniaszAlana L Welm
Sep 2, 2016·Journal of the National Cancer Institute·Eloisa ArbustiniMaurizia Grasso

❮ Previous
Next ❯

Citations

Feb 5, 2019·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R CondorelliN C Turner
Mar 13, 2019·International Journal of Cancer. Journal International Du Cancer·Florence CoussyElisabetta Marangoni
Jun 23, 2019·Cells·Takahiko Murayama, Noriko Gotoh
Aug 6, 2018·Pediatric Radiology·Mary-Louise C Greer
Jan 9, 2020·Journal of Hematology & Oncology·Go J Yoshida
Sep 7, 2019·Oncotarget·Nicci Owusu-BrackettFunda Meric-Bernstam
Sep 14, 2018·Frontiers in Molecular Biosciences·Anna P Sokolenko, Evgeny N Imyanitov
Sep 6, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Xian ChenKhandan Keyomarsi
Nov 2, 2020·Biochimica Et Biophysica Acta. Reviews on Cancer·Oliver TruslerAndrew L Laslett
Oct 22, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Chung Ying ChanBart Cornelissen
Jan 9, 2021·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ming ZhaoFunda Meric-Bernstam
Mar 25, 2021·Cancer Management and Research·Zhitao LiBingqing Hui
Mar 22, 2021·Experimental and Molecular Pathology·Juliana Cristina de SouzaCarolina Cavaliéri Gomes
Jul 24, 2021·Future Science OA·Jason E LongDanilo Maddalo
Aug 7, 2021·Journal of Personalized Medicine·Christos DamaskosDimitrios Dimitroulis
Aug 9, 2021·Progress in Biophysics and Molecular Biology·Krishna DasariJeffrey P Townsend

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.